Helix BioPharma Corp.: Helix Biopharma Corp. Announces Appoi

RICHMOND HILL, ON / ACCESSWIRE / April 18, 2022 / Helix BioPharma Corp. (TSX:HBP) ("Helix" or the "Company"), a clinical-stage biopharmaceutical company developing unique therapies in the field of immuno-oncology

Related Keywords

Canada , Poland , Toronto , Ontario , Richmond Hill , Warsaw , L67 , Canadian , Christopher Maciejewski , Artur Gabor , Jacek Antas , Frank Michalargias , Jerzy Leszczynski , Manual Sciences , Silesian University In Wroclaw , Warsaw Institute Of Technology , Warsaw School Of Economics , Helix Biopharma Corp , Helix Biopharma , Chief Executive Officer , Warsaw Institute , Chief Medical Officer , Medevac Canada , Silesian University , Applied Medical Manual , Warsaw School , Chief Executive , Chief Financial Officer , Looking Statements , Annual Information Form , Helix , Iopharma , Orp , Nnounces , Appointment , Permanent , Independent , Board , Members ,